Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

370
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
370
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

256
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
256
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

1.9K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.9K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

411
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
411
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

378
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
378

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating False Multistation N2 Upstaging From Cross-Contamination During EBUS-TBNA Without ROSE: Insights From a Monte Carlo Analysis.

Journal of bronchology & interventional pulmonology·2026
Same author

The clinical utility of endobronchial ultrasound-guided transbronchial needle aspiration: A single-center experience from the Middle East.

Annals of thoracic medicine·2026
Same author

Endobronchial Actinomycosis - The Great Masquerader.

Annals of African medicine·2026
Same author

Dietary risk factors for non-communicable diseases among Omani adults by latent class analysis and structural equation modelling.

BMC nutrition·2025
Same author

Impact of mitigating obesity, smoking, and physical inactivity on type 2 diabetes mellitus burden in Oman: insights from mathematical modeling.

BMJ open diabetes research & care·2024
Same author

Is High-Flow Nasal Oxygenation a Game Changer in Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration?: A pilot study.

Sultan Qaboos University medical journal·2024

Related Experiment Video

Updated: Sep 30, 2025

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

3.6K

Respiratory Complications after COVID-19.

Issa Al-Jahdhami1, , Adhra Al-Mawali2,3

  • 1Department of Medicine, Armed Forced Hospital, Muscat, Oman.

Oman Medical Journal
|March 14, 2022
PubMed
Summary

Long COVID can cause lasting lung damage, including pulmonary fibrosis, impacting community health. This review explores current knowledge on post-COVID respiratory complications and treatment strategies for physicians.

Keywords:
COVID-19Pulmonary Fibrosis

More Related Videos

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.3K
Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects
06:57

Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects

Published on: February 12, 2021

3.3K

Related Experiment Videos

Last Updated: Sep 30, 2025

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

3.6K
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.3K
Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects
06:57

Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects

Published on: February 12, 2021

3.3K

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic has led to significant short-term morbidity and mortality.
  • Lungs are primary targets of SARS-CoV-2, with increasing concerns about long-term pulmonary sequelae.
  • Respiratory complications post-COVID-19, including fibrosis, are not fully understood even two years into the pandemic.

Purpose of the Study:

  • To review current knowledge on post-COVID-19 respiratory complications.
  • To focus on pulmonary fibrosis as a significant long-term consequence.
  • To outline current and future treatment directions and provide recommendations for physicians.

Main Methods:

  • Literature review of studies on post-COVID-19 respiratory complications.
  • Analysis of data on the prevalence and characteristics of pulmonary fibrosis.
  • Synthesis of information on current therapeutic approaches and recommendations.

Main Results:

  • A wide spectrum of long-term respiratory issues secondary to COVID-19 exists.
  • Pulmonary fibrosis is a notable complication with persistent effects.
  • Current treatments are largely symptomatic and supportive.

Conclusions:

  • Understanding and managing long-term pulmonary sequelae of COVID-19 is crucial.
  • Further research into effective treatments for post-COVID-19 pulmonary fibrosis is needed.
  • Physicians require updated guidance for managing these complex respiratory conditions.